Drug details

Victrelis (boceprevir capsules)

type of HCV Protease Inhibitors

Victrelis (boceprevir) is a protease inhibitor indicated for the treatment of chronic hepatitis C. Victrelis must not be used as a single therapy and should only be used in combination with peginterferon alfa and ribavirin in adult patients with liver disease.

The drug is often used to treat Hepatitis C , Liver disease .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• severe anemia,
• low levels of white blood cells (neutropenia), and
• blood clots (thromboembolic events)

The following drugs are related to Victrelis, either as a replacement or used together:

• Copegus (ribavirin)
• Zepatier (elbasvir and grazoprevir tablets)
• Neupogen (filgrastim injection)
• Releuko (filgrastim-ayow injection)
• Harvoni (ledipasvir and sofosbuvir tablets)
• Twinrix (hepatitis a inactivated & hepatitis b (recombinant) vaccine)
• Ocaliva (obeticholic acid tablets)
• Technivie (ombitasvir, paritaprevir and ritonavir tablets)
• Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
• Pegasys (peginterferon alfa-2a)
• PegIntron and Rebetol Combo Pack (peginterferon alfa-2b and ribavirin combo pack)